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To better understand late outcomes of mitral valve repair, we reviewed the 
cases of 49 consecutive patients who underwent reoperation between January 
1974 and May 1992 for recurrent valve dysfunction after previous valvuloplasty 
for mitral regurgitation. There were 27 men (55%) and 22 women, with a 
median age of 63 years (range 20 to 84 years). Original procedures included 
annuloplasty and posterior leaflet repair in 15 patients (31%), annu!oplasty 
and anterior leaflet repair in 15 (31%), commissural plication in 13 (27%), and 
complex bileaflet repairs in six (12%). Median time between initial mitral 
repair and reoperation was 2.4 years (range 2 months to 25.3 years). Indica, 
tions for reoperation i cluded recurrent severe mitral regurgitation in 34 
patients (70%), hemolytic anemia from mitral regurgitation i  seven (14%), 
mixed mitral regurgitation and stenosis in seven (14%), and isolated mitral 
stenosis in one (2%). Before reoperation, 36 patients were in New York Heart 
Association functional class I I I  and 11 were in class IV. Initial repairs were 
intact at the second operation in 32 patients (65%), and the etiology of 
recurrent mitral regurgitation i these patients was fibrosis or calcification of 
the anulus or leaflets in 22 patients, newly ruptured chordae in seven, and 
perforated leaflets in three. The causes of mitral regurgitation in the 17 
patients whose initial repair had failed included dehiscence of commissural 
repairs in nine patients, dehiscence of ring annuloplasty in four, and break- 
down of chordal or leaflet repair in four. Patients with original repair s
involving the anterior leaflet had a significantly shorter time between opera- 
tions (p = 0.006), In eight patients (16%), the mitral valve was repaired again; 
in the remaining 41 patients (84%), prosthetic replacement was performed. 
Operative mortality rate was 4% (two patients). All eight patients who 
underwent mitral valve rerepair had no mitral regurgitation, trivial regurgi- 
tation, or mild regurgitation at discharge from the hospital. Follow-up was 
100% complete at a mean of 5.1 years (range 1 to 19 years). Forty-one patients 
(87%) were in New York Heart Association functional class I or II, and survival 
at 5 years was 75.3%. Of the eight patients who underwent a second repair, 
seven had no regurgitation, trivial regurgitation, or mild regurgitation at a 
median of 4 years' follow-up. The low mortality associated with reoperation 
supports an aggressive approach toward mitral regurgitation with initial 
repair. A second repair can be performed in selected patients with durable 
results at 4 years. (J Thorac Cardiovasc Surg 1996;111:1177-84) 
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B ecause of the advantages of valvuloplasty over prosthetic replacement, the number of patients 
who undergo mitral valve repair is increasing. 
Techniques of leaflet resection, annuloplasty, and 
chordal replacement have steadily evolved, ~-s and 
most patients with regurgitation caused by degener, 
ative causes are candidates for mitral valve repair. It 
is therefore likely that in the future cardiologists and 
cardiac surgeons will encounter more patients with 
residual or recurrent mitral valve dysfunction after a 
previous repair. 6To better understand causes of late 
failure of mitral valve repair, we reviewed our 
experience with reoperation in these patients and 
focused on surgical findings and operative results. 
Patients and methods 
Between January 1974 and May 1992, 49 consecutive 
patients who had undergone previous mitral valve repair 
underwent reoperation atthe Mayo Clinic for recurrent or 
residual mitral valve dysfunction. Patients with previous 
commissurotomies, congenital mitral valve disease, regur- 
gitation from cardiac or valvular masses, an d previous 
balloon mitral valvuloplasties were excluded from this 
study. Patient characteristics were obtained from clinic 
records; some of the 33 preoperative ariables used in this 
analysis are listed in Table I. 
Follow-up was obtained for all patients through records of 
most recent examination at the Mayo Clinic, letters from 
home health care providers, and reports of the most recent 
echocardiograms. Follow-up information included New 
York Heart Association (NYHA) functional class, the pres- 
ence and degree of mitral valve dysfunction, and any subse- 
quent complications related to the repaired valve. 
Operative mortality was defined as including any deaths 
occurring before discharge fi0m the hospital or within 30 
days after the operative procedure; !ate mortality included 
any subsequent deaths. Late complications were defined 
as those that occurred after discharge from the hospital. 
Data are expressed as medians with ranges. Continuous 
variables were compared with unpaired or paired Stu- 
dent's t tests (two-sided)and analysis of variance; discrete 
variables were compared with the X 2 test. Survival was 
estimated by the Kaplan-Meier method, with the date of 
last operation as the beginning date. Values ofp less than 
0.05 were considered statistically significant. 
Results 
Initial valve repair. The group studied was com- 
posed of 27 men and 22 women with a median age 
at first mitral valve procedure of 58 years (range 19 
to 84 years). Three patients had undergone cardiac 
operations before this first mitral valve repair; two 
patients had undergone coronary artery bypass 
grafting and one patient had und¢rgone aortic valve 
replacement. In this latter patient, the prosthetic 
aortic valve was competent at initial mitral valve 
Table I. Patient characteristics before first mitral 
valve operation 
No. of patients 
Initial mitral valve repair at Mayo Clinic 42 
Initial mitral valve repair elsewhere 7 
Symptoms 
Dyspnea on exertion 41 
Shortness of breath at rest 38 
Angina 11 
Previous hospitalization for CHF 8 
History of endocarditis of mitral valve 3 
History of rheumatic fever 12 





MR by echocardiography 
Moderately severe 4 
Severe 45 
Severe tricuspid regurgitation 3 
CH F, Congestive h art failure; MR, mitral regurgitation. 
Table !I. Types of initial mitral valve repair 
Procedure No. of patients 
Annuloplasty and posterior leaflet repair 15 
Annuloplasty and anterior leaflet repair 15 
Commissural plication 13 
Complex bileaflet repair 6 
repair. Forty-two patients underwent initial valve 
repair at the Mayo Clinic. 
In 43 cases, the indication for initial operation was 
pure mitral regurgitation; in six, it was mixed steno- 
sis and regurgitation. Methods used during initial 
repair of the mitral valve are listed in Table II. At 
initial repair, 17 patients (35%)underwent 19 con- 
comitant cardiovascular p ocedures: coronary artery 
bypass grafting in 13 patients, tricuspid valve repair 
in three, aortic valve replacement in two, and clo- 
sure of a ventricular septal defect in one. 
Intraoperative transesophageal echocardiogra- 
phic assessment of this initial mitral valve repair was 
performed in the last 10 patients. The degree of 
mitral valve regurgitation after initial repair was 
estimated as trivial or none in four patients, mild in 
five, and moderate in one. Seventeen patients had 
postoperativ e transthoracic echocardiograms before 
discharge from the hospital after the initial opera- 
tion. There was no mitral regurgitation or only 
trivial regurgitation i five patients, mild regurgita- 
tion in eight, moderate regurgitation in two, and 
moderately severe or severe regurgitation in two. 
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Table III. Patient characteristics before second 
mitral valve operation 
No. of patients 
Symptoms 
Dyspnea on exertion 40 
Shortness of breath at rest 38 
Previous hospitalization for CHF 9 
Anemia/lethargy 7 
History of mitral valve endocarditis 3 
History of rheumatic fever 12 





MR by echocardiography 
None 1 
Moderate 3 
Moderately severe 6 
Severe 39 
Severe tricuspid regurgitation 9 
CHF, Congestive h art failure; MR, mitral regurgitation. 
The presence of at least mild mitral valve regurgi- 
tation in these latter twelve patients did not predict 
the need for earlier eoperation. 
Reoperation. The interval between initial valve 
repair and reoperation ranged from 2 months to 25 
years (median 2.4 years), and median age at reop- 
eration was 63 years (range 20 to 84). Patient 
Characteristics before reoperation are shown in Ta- 
ble Ill. 
Indications for reoperation were recurrent severe 
mitral regurgitation alone in 34 patients (69%), 
hemolytic anemia in seven (14%), mixed mitral 
regurgitation and stenosis in seven (14%), and iso- 
lated mitral stenosis in one (2%). The seven patients 
with hemolytic anemia represent a unique subgroup 
of patients, as shown in Table IV. In the three 
patients who had undergone previous aortic valve 
replacement, he prosthetic valve was normal at 
time of reoperation. Preoperative echocardiography 
demonstrated annular dilatation in 41 patients, 
thickened leaflets in 26, an eccentric jet in 16, 
ruptured chordae tendineae in 13, mitral valve 
prolapse in 12, and calcification of the anulus in 
seven. 
As seen in Table V, annular dilatation and the 
presence of a central jet were observed more com- 
monly in valves that were repaired again than in 
those that were replaced. Also, thickened leaflets 
and ruptured chordae were more commonly seen in 
valves that were replaced. All patients with a clinical 
Table IV. Patient characteristics of seven patients 
with hemolytic anemia 
No. of patients 
Degree of mitral regurgitation 
Mild 4 
Moderately severe 2 
Severe 1 
Type of initial mitral valve repairs 
Carpentier-Edwards inged valvuloplasty 4 
Dutan ringed valvuloplasty 2 
Commissural nnuloplasty 1 
Time to reoperation ranged from 1.6 to 10.3 months (median 3.3 months): 
history of rheumatic fever underwent mitrai valve 
replacement a reoperation. 
Operative methods were generally uniform: the 
heart was approached through amedian sternotomy 
in 48 patients and through a right thoracotomy in
one patient; the mitral valve was exposed through 
the left atrium in 45 patients and through an atrial 
septotomy after right atriotomy in four patients. In 
32 patients, the original valve repairs were found to 
be intact; in 17 patients, recurrent regurgitation was 
caused by failure of the original repair. Causes of 
mitral regurgitation are shown in Fig. 1. The 22 
cases of fibrodc or calcified leaflets or anuli also 
include those valves described as thickened or re- 
tracted at reoperation. Two of the three patients 
with newly perforated leaflets had documented en- 
docarditis. The median time between initial valvu- 
loplasty and reoperation for patients with intact 
repair was 3.2 years (range 0.16 to 25.3 years), and 
the median time between operations for patients 
with failure of the initial repair was 1.0 year (range 
0.2 to 12.3 years). 
At reoperation, 41 patients underwent mitral 
valve replacement (30 with mechanical prostheses. 
11 With bioprostheses) and eight patients underwent 
a second repair. Methods of second repair were 
wedge resection of the posterior leaflet with poste- 
rior annuloplasty in four patients, wedge resection 
of the posterior leaflet only in two. and annuloplasty 
and wedge resection of the posterior and anterior 
leaflets in one patient each. During reoperation. 19 
patients underwent coiacomitant cardiovascular pro- 
cedures: coronary artery bypass grafting in seven, 
tricuspid valve repair in seven, tricuspid valve re- 
placement in two, closure of atrial septal defect in 
two, and aortic valve replacement in one. For all 
49 patients, duration of cardiopulmonary b pass 
ranged from 42 to 212 minutes (median 91 minutes), 
1180 Cerfolio et aL 




32 (65%) initial repair 
intact 
22 fibrotic or calcified 
leaflet or anulus 
7 newly ruptured 
chordae 





17 (35%) initial repair 
failure 
9 dehiscence of 
commissural annuloplasty 
4 dehiscence of 
ringed annuloplasty 
4 dehiscence of 
chordae/leaflet repair 
Fig. 1. Causes of mitral valve dysfunction at reoperation. 
and duration of aortic occlusion ranged from 15 to 
125 minutes (median 58 minutes). 
Operative mortality rate was 4% (two patients). 
One patient died of multiorgan failure and bilateral 
adrenal hemorrhage. The other death was caused by 
renal failure and gram-negative s pticemia. Nonfa- 
tal complications included new-onset atrial fibrilla- 
tion in three patients, hemorrhage necessitating 
exploration in two patients, respiratory failure in 
two patients, and ischemic olitis in one patient. 
All patients who underwent a second repair of the 
mitral valve underwent echocardiography at dis- 
charge from the hospital. Six of these eight patients 
had no regurgitation or only trivial valve leakage; 
two had mild residual mitral valve regurgitation. 
Late follow-up. Follow-up was complete for all 
patients and ranged from 1 to 19 years (median 5.1 
years). At last assessment, 15 patients were in 
NYHA functional class I, 24 were in NYHA class II, 
eight were in NYHA class III, and none were in 
NYHA class IV. Five-year actuarial survival was 
75.3%. 
Serial echocardiograms were available for all pa- 
tients who underwent a second mitral valve repair; 
median follow-up for these ight patients was four 
years (range 3 to 11 years). Six patients continue to 
have no mitral regurgitation or trivial regurgitation, 
and one patient who had mild mitral regurgitation at
discharge from the hospital had an echocardiogram 
obtained elsewhere 8 years after operation that 
demonstrated moderate regurgitation. The other 
patient who had mild mitral regurgitation at dis- 
charge from the hospital has no evidence of progres- 
sion at ll-year follow-up. 
Late complications have occurred in 12 patients: 
five new rhythm disturbances, five bleeding episodes 
requiring hospitalization, and two strokes. Eleven of 
those 12 late complications occurred in the group of 
41 patients who underwent mitral valve replacement. 
The only late cardiac complication among the group 
of patients who underwent second repair of the mitral 
valve was onset of intermittent a rial fibrillation in one 
patient. 
There were 16 late deaths; eight patients died of 
cardiac causes, including four sudden deaths of 
presumed arrhythmia (all with autopsies). Three 
patients died of progressive congestive heart failure, 
and one died of endocarditis. Two of the late deaths 
were those of patients who underwent mitral valve 
second repair; one died of hepatic failure and the 
other of severe chronic obstructive pulmonary dis- 
ease. 
Discussion 
Valvuloplasty for mitral regurgitation has clear 
advantages over prosthetic replacement. 7 to First, 
the procedure carries a low operative risk. TM 12 In a 
recent report from our institution, the operative 
mortality rate for mitral valve repairs performed 
from 1979 to 1992 was 1.7%. 3 Left ventricular 
function appears to be better in patients who have 
repair of mitral regurgitation rather than valve 
replacementJ 3 Most important, late survival after 
mitral valve repair is improved with respect o that 
after mitral valve replacementJ 4-16 In this study, the 
5-year survival for patients who underwent second 
repair was 100%, whereas it was 71% for those who 
underwent mitral valve replacement. Few studies, 
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Table V. Preoperative echocardiographic characteristics before second rnitraI valve reoperation 
Ruptured 
papillary 
muscle or Annular Leaflet Thickened Annular 
chord dilatation Central jet prolapse leaflets calcification 
No. % No. % No. % No. % No. % No. % 
MV rerepair(n - 8) 0 0 8 100 4 50 2 25 3 38 1 13 
MVreplacement(n = 8) 12 32 33 80 12 29 10 24 23 56 6 15 
MV, Mitral valve. 
For all six echocardiographic variables, p not significant. 
however, have examined the causes of late failure of 
mitral valve repair. 6' 17 
The incidence and cause of failure of mitral 
valvuloplasty vary with the cause of mitral regurgi- 
tation. For example, 5 years after repair of mitral 
regurgitation i a young population with rheumatic 
heart disease, 34% of patients have had valve failure 
and 25% have undergone reoperation, is In contrast, 
among North American patients, most of whom 
have degenerative mitral valve disease, risks of 
reoperation after valvuloplasty were only 5% at 8 
years in one study ~9 and 17% at 10 years in another 
report, z° Although our study was not designed to 
determine incidence of reoperation, the patients 
reviewed seem representative of North American 
patients undergoing mitral valve repair. In this 
study, initial valvuloplasties were performed be- 
tween December 1960 and September 1991. During 
this time 1548 patients underwent mitral valve re- 
pair (exclusion criteria were the same as described 
previously, in this article). The estimated reopera- 
tion rate for mitral valve repair during this interval is 
2.7% (seven had initial repairs elsewhere), although 
we cannot be certain that all patients undergoing 
reoperation returned to our clinic. 
An important aspect of the present study is the 
finding that original repairs were intact in over half 
of patients undergoing reoperation. Thus, late valve 
dysfunction is often due to new degenerative lesions, 
and this finding is similar to that reported by Mar- 
wick and colleagues. 17Echocardiography is an in- 
dispensable tool for determining which patients are 
candidates for mitral valve repair 21 and is valuable 
during operation to assess valvuloplasty, z2 There 
were, however, no obvious echocardiographic fea- 
tures that would have predicted late failure in 
patients who had intact repairs at reoperation. 
Dehiscence of initial repair may be avoidable, and 
the incidence of this late complication would be 
expected to diminish with increasing operative x- 
perience. Also, current methods of posterior ring 
annuloplasty hat more venly distribute tension and 
protect leaflet reconstruction may carry lower inci- 
dences of dehiscence than that of commissural 
plication.3, 23 Certainly, judgment is necessary in 
applying valvuloplasty to leaflet tissue thinned by 
fibroelastic deficiency and to valves with excessive 
calcification of leaflets or anulus. Grossi and col- 
leagues 2° advocate decalcification of the anulus or 
leaflet. Although operative mortality rate was 6.2% 
in their series, there was no adverse ffect of decal- 
cification on long-term freedom from reoperation. 
Our clinical experience suggests that calcification of 
the mitral valve anulus does complicate valve repair, 
especially construction of a secure annuloplasty. 
Noticeably absent from this report was left ven- 
tricular outflow obstruction 24-27 as a cause of reop- 
eration. Intraoperative chocardiographic studies 
show that in almost every instance outflow obstruc- 
tion as a result of systolic anterior motion of the 
mitral valve early after mitral valve repair is associ- 
ated with hyperdynamic left ventricular function and 
intravascular volume depletion. 2z When this situa- 
tion is identified, intravascular volume augmenta- 
tion and discontinuation of inotropic agents pro- 
duce dramatic reduction in both mitral regurgitation 
and left ventricular outflow obstruction. This study 
gives further support to the notion that outflow 
obstruction is transient and does not mandate revi- 
sion of the repair. 
In seven patients, reoperation was necessary be- 
cause of hemolytic anemia. This is a rare but 
well-recognized complication of both valve replace- 
ment and valve repair. 28-31 The diagnosis is made by 
a low serum haptoglobin level, high serum lactate 
dehydrogenase level, schistocytosis, and lack of any 
identifiable cause of anemia or hemolysis other than 
mitral regurgitation. In this study, hemolytic anemia 
occurred relatively early after valve repair, and in 
most instances the degree of mitral regurgitation 
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was only mild or moderate. The mechanism was an 
eccentric jet of blood directed against a nonendo- 
thelialized portion of an annuloplasty ring or 
pledget. In all cases, hemolysis was corrected by 
reoperation; in one case, the regurgitation was 
eliminated by removal of a section of annuloplasty 
ring. 
There are few published data on long-term results 
of second repair of the mitral valve. The echocar- 
diographic follow-ups of our eight patients who 
underwent second repair showed little or no pro- 
gression of mitral valve regurgitation, and the results 
seem durable at 4 years. Certainly, care should be 
exercised in performing a second valvuloplasty, and 
prosthetic replacement is preferable unless valvular 
tissue is quite sturdy and the cause of failure is easily 
identified and corrected. 
In conclusion, reoperation after mitral valve re- 
pair is relatively safe, and intermediate-term results 
are satisfactory; operative risk was only slightly 
higher than that observed for initial valve repair 
(4% vs 1.7%). In most patients who undergo reop- 
eration, initial repairs are intact and recurrent mitral 
regurgitation is the result of new degenerative le- 
sions. Patients with failure of initial valvuloplasty 
usually require reoperation earlier than do patients 
with new degenerative lesions. Reoperation for left 
ventricular outflow obstruction is distinctly uncom- 
mon, certainly less common as a late complication of 
valvuloplasty than mechanical hemolytic anemia. 
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Discussion 
Dr. R. Scott Mitchell (Stanford, Calif.). I congratulate 
you on an excellent presentation. You and your associates 
at the Mayo Clinic once again have brought valuable 
information from your vast clinical experience to this 
meeting. From a total of more than 1500 patients under- 
going mitral valve repair in a 30-year interval, 49 patients, 
or just more than 2%, required second mitral valve 
operations. The interval between initial valve repair and 
reoperation ranged from 2 months to 25 years, which 
allows us a truly long-term view of mitral valve repair. As 
you mentioned, patients with left ventricular outflow tract 
obstruction, which you note to be transient and really 
associated only with the acute phase, were noticeably 
absent. 
Of the eight patients who underwent mitral valve 
rerepair, annular dilatation was noted in eight patients, a
central regurgitant jet was noted in four, thickened leaflets 
were noted in three, and leaflet prolapse was noted in two. 
No patient with a ruptured papillary muscle or cord 
underwent rerepair, although that echocardiographic vari- 
able failed to achieve statistical significance. Do you think 
that would become a significant factor with a greater 
number of patients? 
Dr. Cerfolio. As more patients come to mitral valve 
repair, there will be a greater number with mitral regur- 
gitation. The surgical and echocardiographic experience 
and expertise are increasing, and I believe that with more 
patients examined the echocardiographic variables per- 
taining to the ability to perform rerepair will become 
significant. 
Dr. Mitchell. Posterior leaflet resection with or with- 
out annuloplasty accounted for seven of the eight 
rerepairs. I think that the method of failure is instruc- 
tive. Sixty-five percent of your repairs were intact with 
progressive calcification, with ruptured chordae ac- 
counting for these failures. Seventeen of your patients, 
however, had dehiscence of the repair. Because most of 
these operations were done at the Mayo Clinic, we 
might learn something. Because that the anulus under- 
goes active deformation, was there any correlation 
between the type of ring, flexible versus rigid, and the 
propensity for dehiscence? 
Dr. Cerfolio. This experience did not contain a signifi- 
cant number of patients to evaluate annuloplasty tech- 
niques. This was a topic of another project in which 
commissural, "full-ring," and posterior annuloplasty were 
compared and there was no difference (Odell JA, Schaff 
HV, Orszulak TA. Early results of a simplified method of 
mitral valve annuloplasty. Circulation In press.). However, 
those methods were performed as part of an evolutionary 
process, and the follow-up was shortest for the most 
recent, posterior annuloplasty. 
Dr. Mitchell. The patients with hemolytic anemia rep- 
resent a very interesting subset, and I wondered whether 
you could clarify this for us. These patients seemed to 
require reoperation rather early. Was rerepair possible in 
these patients? I could not really determine that from the 
manuscript. 
Dr. Cerfolio. Since acceptance of the abstract, we have 
encountered two more patients with this finding. We were 
able to rerepair the valve in three of those nine patients, 
and their time to reoperation was much different from 
that of the other patients in this study. Their median time 
to reoperation was 3 months, with a range of 1 to 10 
months, and their amount of mitral regurgitation before 
operation was indeed significantly less than that of the 
other patients in this study. The patients with hemolytic 
anemia after mitral valve repair had only mild or moder- 
ate mitral regurgitation i stead of the severe mitral regur- 
gitation seen in others. All of these patients have mechan- 
ically induced hemolytic anemia from recurrent mitral 
regurgitation after mitral valve repair. 
Dr. Carlos Gomez Duran (Missoula, Mont.). This is a 
very interesting and timely presentation. We have also had 
cases of hemolysis, particularly in very young patients, 
forcing reoperation i dependently of the degree of regur- 
gitation. My question is whether you have experience with 
the use of ]3-blockers. We have found that slowing down 
the heart rate significantly reduced the need for reopera- 
tion. 
Dr. Cerfolio. The median age of the nine patients who 
had hemolytic anemia was 59 years, with a range of 35 to 
84 years, so I cannot comment on a younger population 
with this problem. Moreover, it is difficult to determine 
the number of patients with hemolytic anemia fter mitral 
valve repair. The degree of hemolysis is variable and may 
be subclinical in some. 
Dr. Gomez Duran. We know that the two main causes 
of reoperation are technical aspects and etiology. From a 
technical point of view, we believe that chordal transfer is 
easier to perform than chordal shortening. It does not 
require any judgment o do it properly. 
My second question is related to etiology. Our standard 
finding is that rheumatic valves are more difficult o repair 
and less stable than valves in degenerative cases. Do your 
findings support his view? 
Dr. Cerfolio. We statistically reviewed the etiologic 
impact of rheumatic fever. None of the patients with a 
clinical history of rheumatic fever were judged to be 
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candidates for rerepair. Most of these leaflets were de- 
scribed as either thickened or retracted, and this is 
probably the reason that they were not repaired. 
Dr. Gomez Duran. Another point I would like to make 
is that we recently have found another cause of early 
reoperation that has not been mentioned before and of 
which we were not aware. This is the very fast remod- 
eling of the left ventricle after operation. Some patients 
with successful chordal shortening to the anterior leaf- 
let and no residual regurgitation required reoperation 
for anterior prolapse within 3 months after operation. 
We could show echocardiographically that these ventri- 
cles had come down in size by about 30% in a few days. 
Probably our patient population is different from yours. 
Dr. Cerfolio. There may be one patient in our series 
who had this phenomenon that you have described. 
Dr. George Kafronni (LaCanada, Calif). Of the more 
than a thousand patients, what percentage have been 
completely followed up to the present? 
Dr. Cerfolio. We are in the process of accumulating that 
information but have no figures at this time. 
Dr. Kafrouni. So you do not know how many were 
possibly reoperated on elsewhere? 
Dr. Cerfolio. That is correct. The 2.7% figure is an 
estimate of the reoperation rate. This number is derived 
from the total number of cases done during the same 
time period as the first mitral valve repair with the same 
exclusion criteria, and since only 42 patients' initial 
mitral valve repairs were performed at the Mayo Clinic, 
we used this as the numerator to achieve our rough 
estimate. It is possible and likely that some patients who 
underwent their first mitral valve repair at the Mayo 
Clinic required a second mitral valve procedure lse- 
where. 
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